This Study Aims to Compare the Efficacy and Safety of Lumateperone and Cariprazine in Patients With Bipolar I Depression Using Montgomery-Åsberg Depression Rating Scale (MADRS) and Clinical Global Impression Bipolar Severity Scale (CGI-BP-S) and Recording Treatment Emergent Adverse Effects.
PHASE4
This study aims to compare the efficacy and safety of lumateperone and cari...
Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
N/A
There is no consensus on the treatment of Impulse Control Disorder (ICD) in...
Status
Not Yet Recruiting
Location
Service de Neurologie et Centre d'Investigation Clinique CHRU de Besançon,
Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
PHASE2
There is no consensus on the treatment of Impulse Control Disorder (ICD) in...